Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.

MLA

Deni, Ioanna, et al. “Mitigating the Risk of Antimalarial Resistance via Covalent Dual-Subunit Inhibition of the Plasmodium Proteasome.” Cell Chemical Biology, vol. 30, no. 5, May 2023, p. 470. EBSCOhost, https://doi.org/10.1016/j.chembiol.2023.03.002.

APA

Deni, I., Stokes, B. H., Ward, K. E., Fairhurst, K. J., Pasaje, C. F. A., Yeo, T., Akbar, S., Park, H., Muir, R., Bick, D. S., Zhan, W., Zhang, H., Liu, Y. J., Ng, C. L., Kirkman, L. A., Almaliti, J., Gould, A. E., Duffey, M., O’Donoghue, A. J., … Fidock, D. A. (2023). Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome. Cell Chemical Biology, 30(5), 470. https://doi.org/10.1016/j.chembiol.2023.03.002

Chicago

Deni, Ioanna, Barbara H Stokes, Kurt E Ward, Kate J Fairhurst, Charisse Flerida A Pasaje, Tomas Yeo, Shirin Akbar, et al. 2023. “Mitigating the Risk of Antimalarial Resistance via Covalent Dual-Subunit Inhibition of the Plasmodium Proteasome.” Cell Chemical Biology 30 (5): 470. doi:10.1016/j.chembiol.2023.03.002.